The 20 Best Prostate Cancer Doctors near Flushing, NY

James Wysock is a Urologist in New York, New York. Dr. Wysock is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Urachal Cyst, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

William Huang is a Urologist in New York, New York. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy.

Herbert Lepor is a Urologist in New York, New York. Dr. Lepor is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Orchiectomy.

Christopher Barbieri is a Urologist in New York, New York. Dr. Barbieri is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Vasectomy.

I am a physician dedicated to improving patient care. I completed my training at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. I focus on a wide array of interventional radiological and surgical techniques, including image guided procedures, focal prostate cancer therapy, prostate artery embolization and much more.I hope that you find our practice a place of caring, education and access to some of the latest therapies in prostate cancer care as well as treatments for enlarged prostates. Dr. Rastinehad is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Enlarged Prostate (BPH), Familial Prostate Cancer, Prostatic Artery Embolization, and Prostatectomy.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy.

An internationally renowned expert in prostate cancer treatment and radiation oncology pioneer, Louis Potters, MD, FASTRO, FABS, FACR serves as Senior Vice President and Deputy Physician-in-Chief of the Northwell Cancer Institute while chairing its Department of Radiation Medicine. His contributions span clinical excellence, research innovation, and healthcare policy development. As a key architect of national cancer treatment guidelines and advisor to the US Nuclear Regulatory Commission, Dr. Potters has helped shape modern radiation oncology standards and safety protocols.His distinguished service includes positions on the Commission on Cancer executive committee, National Quality Forum panels, and multiple Health and Human Services committees, where he has been instrumental in advancing healthcare quality nationwide. As senior editor of Practical Radiation Oncology and editorial board member for leading journals including Oncology and Brachytherapy, he continues to guide professional discourse and scientific advancement in the field. A member of the prestigious Alpha Omega Alpha honor society, Dr. Potters has demonstrated exceptional commitment to medical excellence throughout his career. He recognized year over year in a number of Best Doctor awards by Castle Connolly, is featured in New York Magazine and as a NY Times SuperDoc.Throughout his 32-year clinical practice treating thousands of prostate cancer patients, Dr. Potters has pioneered innovative approaches to patient care and quality assurance. His leadership of one of the nation's largest radiation oncology departments has fostered excellence in patient care, groundbreaking research, and comprehensive medical education. The Smarter Radiation Oncology program he developed has gained international recognition for setting new standards in quality metrics, safety protocols, and patient experience. His academic contributions include over 200 peer-reviewed publications that have significantly advanced the field of radiation oncology and prostate cancer treatment.Under his guidance, the Northwell Health Department of Radiation Medicine has become a leading force in implementing cutting-edge treatments while training the next generation of oncology leaders. Dr. Potters continues to drive innovation in personalized cancer care, process improvement, and clinical outcomes, maintaining Northwell's position at the forefront of modern oncology practice. Dr. Potters is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Ketan Badani is a Urologist in Long Island City, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Charles Drake is an Internal Medicine provider in New York, New York. Dr. Drake is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Prostatectomy.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Jim Hu is a Urologist in New York, New York. Dr. Hu is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy.

William Oh is an Oncologist in New York, New York. Dr. Oh is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Prostatectomy.

Matthew Galsky is a Hematologist and an Oncologist in New York, New York. Dr. Galsky is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Galsky is currently accepting new patients.

Sean Mcbride is a Radiation Oncologist in New York, New York. Dr. Mcbride has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Prostatectomy, and Gastrostomy. Dr. Mcbride is currently accepting new patients.

Himanshu Nagar is a Radiation Oncologist in New York, New York. Dr. Nagar is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, Hodgkin Lymphoma, and Prostatectomy. Dr. Nagar is currently accepting new patients.

Douglas Scherr is a Urologist in New York, New York. Dr. Scherr is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

Cora Sternberg is an Oncologist in New York, New York. Dr. Sternberg is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Sternberg is currently accepting new patients.

Howard Scher is an Oncologist in New York, New York. Dr. Scher is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Orchiectomy, and Prostatectomy. Dr. Scher is currently accepting new patients.

Behfar Ehdaie is a Urologist in New York, New York. Dr. Ehdaie is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy.

Philip Kantoff is an Oncologist in New York, New York. Dr. Kantoff is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Orchiectomy, and Prostatectomy.